As per reliable sources, Bengaluru-based HealthPlix Technologies Pvt. Ltd. has raised USD 13.5 million in its ongoing Series B round, which was led by Lightspeed Venture Partners. The fundraising also saw participation from established investors such as Kalaari Capital, JSW Ventures, and Chiratae Ventures.
This takes the health-tech startup's overall valuation to USD 17.5 million, cited sources with relevant information.
HealthPlix's Electronic Medical Record (EMR) program has been gaining considerable momentum among healthcare professionals as it provides clinical decision-making assistance and produces e-prescriptions. The company claims that over USD 1.1 billion in drug and diagnostic spending is recorded each year.
Sandeep Gudibanda, CEO and Co-Founder of HealthPlix, reportedly said that the Indian government is considering making a patient's health history readily accessible to not just their respective primary care physician but also to any doctor.
Meanwhile, Co-Founder Raghuraj Sunder Raju expressed that the team is doubling down on their efforts to aid doctors to provide in-person or remote consultations to their patients using the same digital platform seamlessly.
Vaibhav Agrawal, a Partner at Lightspeed Ventures, mentioned that whichever platform earns the doctor’s confidence will have supreme authority over the USD 88 billion in healthcare spending.
According to the press release, HealthPlix will use the funds to achieve its goal of 5x growth by expanding its doctor base in established markets, introducing new geographical regions and medical specialties, as well as investing in newer teams and products.
The Bengaluru-based startup was founded by Prasad Basavaraj, Raghuraj Sunder Raju, and Sandeep Gudibanda in 2016. Its mission includes offering clinical software for doctors to ease operational experience as well as improve patient outcomes.
If market speculations are right, there has been a significant increase in deal-making activities in the Indian health-tech startup market. Also, telemedicine, wearable devices, health & wellness, e-pharma, and diagnostics have all seen significant growth in their use.
Source Credit –